<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>GLP Ladder guides</title><description>Free, unit-tested calculators and charts for retatrutide, tirzepatide and semaglutide: dose-level plotter, mg-to-units, reconstitution, titration, cost and storage. Research and education only.</description><link>https://glpladder.com/</link><language>en-us</language><atom:link href="https://glpladder.com/rss.xml" rel="self" type="application/rss+xml"/><item><title>Foundayo Dosing Schedule per the FDA Label</title><link>https://glpladder.com/guides/foundayo-dosing-schedule/</link><guid isPermaLink="true">https://glpladder.com/guides/foundayo-dosing-schedule/</guid><description>Foundayo (orforglipron) dosing schedule from the FDA label (revised 7/2026): the 0.8 mg start, 30-day steps to 17.2 mg, missed doses and interactions.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Dosing schedules</category></item><item><title>Foundayo Savings Card and Price (2026)</title><link>https://glpladder.com/guides/foundayo-savings-card/</link><guid isPermaLink="true">https://glpladder.com/guides/foundayo-savings-card/</guid><description>Foundayo savings card terms and prices as shown Oct 21, 2026: $25 covered fills, LillyDirect self-pay from $149, the $649 list price and the Medicare Bridge.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Savings and cost</category></item><item><title>Foundayo vs Wegovy Pill: Label Facts Compared</title><link>https://glpladder.com/compare/foundayo-vs-wegovy-pill/</link><guid isPermaLink="true">https://glpladder.com/compare/foundayo-vs-wegovy-pill/</guid><description>Foundayo vs Wegovy pill from the FDA labels: dose ladders, food and water rules, missed doses, half-life, trial results and who each pill is approved for.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>semaglutide</category></item><item><title>Missed a GLP-1 Dose? What Each FDA Label Says</title><link>https://glpladder.com/guides/glp1-missed-dose/</link><guid isPermaLink="true">https://glpladder.com/guides/glp1-missed-dose/</guid><description>Missed a GLP-1 dose? The FDA label rules side by side for Wegovy, Ozempic, Zepbound, Mounjaro and Foundayo: time windows, skips, restarts and day changes.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Dosing schedules</category><category>semaglutide</category><category>tirzepatide</category></item><item><title>Mounjaro vs Zepbound: Same Tirzepatide, Different Labels</title><link>https://glpladder.com/compare/mounjaro-vs-zepbound/</link><guid isPermaLink="true">https://glpladder.com/compare/mounjaro-vs-zepbound/</guid><description>Mounjaro vs Zepbound from the FDA labels: same tirzepatide, different indications, one 2.5 to 15 mg ladder, pens and vials, storage, trials and coverage.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>tirzepatide</category></item><item><title>Ozempic vs Wegovy: Same Drug, Different Labels</title><link>https://glpladder.com/compare/ozempic-vs-wegovy/</link><guid isPermaLink="true">https://glpladder.com/compare/ozempic-vs-wegovy/</guid><description>Ozempic vs Wegovy from the FDA labels: one molecule, different indications, dose ladders (2 mg vs 2.4 and 7.2 mg), pens, pills, missed-dose rules and switching.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>semaglutide</category></item><item><title>Wegovy Injection Sites: What the Label Says</title><link>https://glpladder.com/guides/wegovy-injection-sites/</link><guid isPermaLink="true">https://glpladder.com/guides/wegovy-injection-sites/</guid><description>Wegovy injection sites per the FDA label: abdomen, thigh or upper arm, rotation, the 2-inch belly-button rule, pen vs syringe vs FlexTouch, storage, disposal.</description><pubDate>Wed, 21 Oct 2026 00:00:00 GMT</pubDate><category>Using the label</category><category>semaglutide</category></item><item><title>Ozempic Savings Card: Eligibility &amp; Price (2026)</title><link>https://glpladder.com/guides/ozempic-savings-card/</link><guid isPermaLink="true">https://glpladder.com/guides/ozempic-savings-card/</guid><description>Ozempic savings card terms ($25, $100 monthly cap, 48 months), NovoCare self-pay prices and Medicare rules, as shown on Novo Nordisk pages on Oct 19, 2026.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Savings and cost</category><category>semaglutide</category></item><item><title>Zepbound Savings Card: Eligibility &amp; Price (2026)</title><link>https://glpladder.com/guides/zepbound-savings-card/</link><guid isPermaLink="true">https://glpladder.com/guides/zepbound-savings-card/</guid><description>Zepbound savings card eligibility and prices as shown Oct 19, 2026: $25 covered fills, $499 not covered, KwikPen card, LillyDirect self-pay and GoodRx facts.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Savings and cost</category><category>tirzepatide</category></item><item><title>GLP-1 Plotter Tools Compared: Features and Models</title><link>https://glpladder.com/guides/glp1-plotter-alternatives/</link><guid isPermaLink="true">https://glpladder.com/guides/glp1-plotter-alternatives/</guid><description>A neutral feature table of GLP-1 plotter and dose-tracking tools for retatrutide, tirzepatide and semaglutide, plus what a level plotter can and cannot show.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Tools</category><category>retatrutide</category><category>tirzepatide</category><category>semaglutide</category></item><item><title>GLP-3 vs GLP-1: What the Nickname Means</title><link>https://glpladder.com/compare/glp-3-vs-glp-1/</link><guid isPermaLink="true">https://glpladder.com/compare/glp-3-vs-glp-1/</guid><description>GLP-3 is not a hormone or a drug class. It is a nickname for retatrutide. Compare GLP-1, dual and triple agonists by receptor targets, trial results and status.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>retatrutide</category><category>tirzepatide</category><category>semaglutide</category></item><item><title>Is Retatrutide FDA Approved? Status as of Oct 2026</title><link>https://glpladder.com/guides/is-retatrutide-fda-approved/</link><guid isPermaLink="true">https://glpladder.com/guides/is-retatrutide-fda-approved/</guid><description>Retatrutide (nicknamed GLP-3) is not FDA approved as of Oct 19, 2026. Dated timeline of trials, FDA warning letters, registry status and the planned 2027 BLA.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Regulatory status</category><category>retatrutide</category></item><item><title>Mounjaro Dosing Schedule per the FDA Label</title><link>https://glpladder.com/guides/mounjaro-dosing-schedule/</link><guid isPermaLink="true">https://glpladder.com/guides/mounjaro-dosing-schedule/</guid><description>The Mounjaro dosing schedule from the FDA label: 2.5 mg start, 2.5 mg steps after 4+ weeks, 15 mg adult and 10 mg pediatric maximums, and SURPASS-2 results.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosing schedules</category><category>tirzepatide</category></item><item><title>Mounjaro Savings Card: Eligibility &amp; Price (2026)</title><link>https://glpladder.com/guides/mounjaro-savings-card/</link><guid isPermaLink="true">https://glpladder.com/guides/mounjaro-savings-card/</guid><description>Mounjaro savings card terms as shown Oct 19, 2026: $25 covered fills, $499 when not covered, monthly and yearly caps, and the $499 LillyDirect self-pay price.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Savings and cost</category><category>tirzepatide</category></item><item><title>Ozempic Dosing Schedule per the FDA Label</title><link>https://glpladder.com/guides/ozempic-dosing-schedule/</link><guid isPermaLink="true">https://glpladder.com/guides/ozempic-dosing-schedule/</guid><description>Ozempic dosing schedule from the FDA label: 0.25 mg start, 0.5, 1 and 2 mg steps of 4+ weeks, which pen gives each dose, missed doses and 56-day storage.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosing schedules</category><category>semaglutide</category></item><item><title>Retatrutide Dosage Chart: Published Trial Schedules</title><link>https://glpladder.com/guides/retatrutide-dosage-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/retatrutide-dosage-chart/</guid><description>Retatrutide dose schedules from Phase 3 TRIUMPH and Phase 2 trials: 2 mg start, steps every 4 weeks to 4, 9 or 12 mg, with dates and per-arm results.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosage charts</category><category>retatrutide</category></item><item><title>Retatrutide Dose in Units: Conversion Chart</title><link>https://glpladder.com/guides/retatrutide-units-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/retatrutide-units-chart/</guid><description>Convert retatrutide mg to U-100 units at 2.5, 3.333, 5, 10 and 20 mg/mL, with the formula, worked examples and the 2 to 12 mg trial steps in units.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Units charts</category><category>retatrutide</category></item><item><title>Retatrutide Half-Life: How Long It Stays in Your System</title><link>https://glpladder.com/guides/retatrutide-half-life/</link><guid isPermaLink="true">https://glpladder.com/guides/retatrutide-half-life/</guid><description>Retatrutide&apos;s half-life is about 6 days. Elimination math, time to steady state, the 1.8 weekly accumulation ratio and washout after 2 to 8 weeks.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Pharmacokinetics</category><category>retatrutide</category></item><item><title>Retatrutide Phase 3 Results: TRIUMPH-1, -2, -3</title><link>https://glpladder.com/guides/retatrutide-trial-results/</link><guid isPermaLink="true">https://glpladder.com/guides/retatrutide-trial-results/</guid><description>Retatrutide trial results by dose for TRIUMPH-1 to -4, TRANSCEND-T2D-1 and Phase 2, with both estimands, kg and lb changes and the 104-week caveat.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Trial results</category><category>retatrutide</category></item><item><title>Retatrutide Reconstitution Chart (Vial × Water → Units)</title><link>https://glpladder.com/guides/retatrutide-reconstitution-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/retatrutide-reconstitution-chart/</guid><description>Lab arithmetic for retatrutide research vials: mg/mL concentration and U-100 unit readings for 5 to 60 mg vials with 1, 2 or 3 mL of water.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Reconstitution charts</category><category>retatrutide</category></item><item><title>Retatrutide Side Effects: Trial Rates by Dose</title><link>https://glpladder.com/guides/retatrutide-side-effects/</link><guid isPermaLink="true">https://glpladder.com/guides/retatrutide-side-effects/</guid><description>Retatrutide side effects by dose from TRIUMPH-1 to -4, TRANSCEND-T2D-1 and Phase 2: nausea, dysesthesia, discontinuations, and what is not yet published.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Side effects</category><category>retatrutide</category></item><item><title>Retatrutide vs Semaglutide: Trial Results and Status</title><link>https://glpladder.com/compare/retatrutide-vs-semaglutide/</link><guid isPermaLink="true">https://glpladder.com/compare/retatrutide-vs-semaglutide/</guid><description>Retatrutide vs semaglutide side by side: receptor targets, approval status, half-life, dose ladders, TRIUMPH-1 vs STEP 1 weight results and side-effect rates.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>retatrutide</category><category>semaglutide</category></item><item><title>Retatrutide vs Tirzepatide vs Semaglutide Compared</title><link>https://glpladder.com/compare/retatrutide-vs-tirzepatide-vs-semaglutide/</link><guid isPermaLink="true">https://glpladder.com/compare/retatrutide-vs-tirzepatide-vs-semaglutide/</guid><description>Retatrutide vs tirzepatide vs semaglutide in one table: receptor targets, status, half-life, dose ladders, pivotal trial results and side-effect rates.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>retatrutide</category><category>tirzepatide</category><category>semaglutide</category></item><item><title>Retatrutide vs Tirzepatide: Weight Loss, Dosing, Status</title><link>https://glpladder.com/compare/retatrutide-vs-tirzepatide/</link><guid isPermaLink="true">https://glpladder.com/compare/retatrutide-vs-tirzepatide/</guid><description>Retatrutide vs tirzepatide side by side: receptor targets, approval status, half-life, dose ladders, TRIUMPH-1 vs SURMOUNT-1 results and side-effect rates.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>retatrutide</category><category>tirzepatide</category></item><item><title>Semaglutide Dosage Chart: Wegovy &amp; Ozempic Label Doses</title><link>https://glpladder.com/guides/semaglutide-dosage-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/semaglutide-dosage-chart/</guid><description>Wegovy and Ozempic dosage charts from the FDA labels: every titration step by week, the Wegovy pill ladder, 7.2 mg Wegovy HD, missed-dose rules and pens.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosage charts</category><category>semaglutide</category></item><item><title>Semaglutide Dose in Units: Conversion Chart</title><link>https://glpladder.com/guides/semaglutide-units-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/semaglutide-units-chart/</guid><description>Semaglutide units chart: every Wegovy and Ozempic label dose converted to U-100 syringe units at 1, 2, 2.5 and 5 mg/mL, with the formula and worked examples.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Units charts</category><category>semaglutide</category></item><item><title>Semaglutide Half-Life: How Long It Stays in Your System</title><link>https://glpladder.com/guides/semaglutide-half-life/</link><guid isPermaLink="true">https://glpladder.com/guides/semaglutide-half-life/</guid><description>Semaglutide half-life is about 1 week per the FDA labels: how much remains day by day, time to steady state, and how long Wegovy and Ozempic stay in the body.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Pharmacokinetics</category><category>semaglutide</category></item><item><title>Semaglutide Reconstitution Chart (Vial × Water → Units)</title><link>https://glpladder.com/guides/semaglutide-reconstitution-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/semaglutide-reconstitution-chart/</guid><description>Semaglutide reconstitution chart: mg/mL and U-100 units for 2, 5, 10 and 20 mg vials with 1–3 mL water, and why Wegovy and Ozempic pens are never mixed.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Reconstitution charts</category><category>semaglutide</category></item><item><title>Semaglutide Side Effects: Trial Rates by Dose</title><link>https://glpladder.com/guides/semaglutide-side-effects/</link><guid isPermaLink="true">https://glpladder.com/guides/semaglutide-side-effects/</guid><description>Semaglutide side effects from the FDA labels: Wegovy 2.4 mg and 7.2 mg vs placebo, Ozempic 0.5 mg and 1 mg rates, the boxed warning and the 2026 label change.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Side effects</category><category>semaglutide</category></item><item><title>Tirzepatide Dosage Chart: Zepbound &amp; Mounjaro Label Doses</title><link>https://glpladder.com/guides/tirzepatide-dosage-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/tirzepatide-dosage-chart/</guid><description>Tirzepatide dosing chart from the FDA labels: 2.5 mg start, 2.5 mg steps every 4+ weeks to 15 mg, Zepbound maintenance doses, missed-dose rule and strengths.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosage charts</category><category>tirzepatide</category></item><item><title>Tirzepatide Dose in Units: Conversion Chart</title><link>https://glpladder.com/guides/tirzepatide-units-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/tirzepatide-units-chart/</guid><description>Convert tirzepatide mg to U-100 units at 5 to 30 mg/mL, with the formula, a 2.5 mg example, the 2.4 mg question, and how the FDA labels measure doses in mL.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Units charts</category><category>tirzepatide</category></item><item><title>Tirzepatide Half-Life: How Long It Stays in Your System</title><link>https://glpladder.com/guides/tirzepatide-half-life/</link><guid isPermaLink="true">https://glpladder.com/guides/tirzepatide-half-life/</guid><description>Tirzepatide half-life is about 5 days (Zepbound label: 5–6 days). See the decay formula, the fraction left by day, steady state at 4 weeks and washout times.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Pharmacokinetics</category><category>tirzepatide</category></item><item><title>Tirzepatide Reconstitution Chart (Vial × Water → Units)</title><link>https://glpladder.com/guides/tirzepatide-reconstitution-chart/</link><guid isPermaLink="true">https://glpladder.com/guides/tirzepatide-reconstitution-chart/</guid><description>Tirzepatide reconstitution chart: mg/mL and U-100 units for 10–60 mg vials in 1–3 mL, a 30 mg example, and why FDA-approved vials need no mixing.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Reconstitution charts</category><category>tirzepatide</category></item><item><title>Tirzepatide Side Effects: Trial Rates by Dose</title><link>https://glpladder.com/guides/tirzepatide-side-effects/</link><guid isPermaLink="true">https://glpladder.com/guides/tirzepatide-side-effects/</guid><description>Zepbound and Mounjaro side-effect rates by dose from the FDA labels: nausea, diarrhea, hair loss (7.1% of women vs 0.5% of men) and the boxed warning.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Side effects</category><category>tirzepatide</category></item><item><title>Tirzepatide vs Semaglutide: SURMOUNT-5 and Label Facts</title><link>https://glpladder.com/compare/tirzepatide-vs-semaglutide/</link><guid isPermaLink="true">https://glpladder.com/compare/tirzepatide-vs-semaglutide/</guid><description>Tirzepatide vs semaglutide compared: SURMOUNT-5 head-to-head results, SURPASS-2 in diabetes, label dose ladders, half-lives and side-effect rates.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>tirzepatide</category><category>semaglutide</category></item><item><title>Wegovy Dosing Schedule per the FDA Label</title><link>https://glpladder.com/guides/wegovy-dosing-schedule/</link><guid isPermaLink="true">https://glpladder.com/guides/wegovy-dosing-schedule/</guid><description>Wegovy dosing schedule and dose chart from the FDA label (revised 6/2026): weekly pen steps to 2.4 mg, the 7.2 mg HD option, the pill ladder and missed doses.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosing schedules</category><category>semaglutide</category></item><item><title>Wegovy Savings Card: Eligibility &amp; Price (2026)</title><link>https://glpladder.com/guides/wegovy-savings-card/</link><guid isPermaLink="true">https://glpladder.com/guides/wegovy-savings-card/</guid><description>Wegovy savings card terms, NovoCare self-pay prices, list price and the Medicare $50 bridge, as shown on Novo Nordisk pages on Oct 19, 2026.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Savings and cost</category><category>semaglutide</category></item><item><title>Wegovy vs Zepbound: Doses, Results, Storage, Price</title><link>https://glpladder.com/compare/wegovy-vs-zepbound/</link><guid isPermaLink="true">https://glpladder.com/compare/wegovy-vs-zepbound/</guid><description>Wegovy vs Zepbound from the FDA labels: indications, dose ladders, pens and vials, storage, missed doses, SURMOUNT-5 results and Oct 2026 self-pay prices.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Comparisons</category><category>semaglutide</category><category>tirzepatide</category></item><item><title>Zepbound Dosing Schedule per the FDA Label</title><link>https://glpladder.com/guides/zepbound-dosing-schedule/</link><guid isPermaLink="true">https://glpladder.com/guides/zepbound-dosing-schedule/</guid><description>Zepbound dosing schedule from the FDA label: 2.5 mg start, 2.5 mg steps after 4+ weeks, maintenance by indication, the 15 mg maximum and missed doses.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Dosing schedules</category><category>tirzepatide</category></item><item><title>Zepbound Injection Sites: What the Label Says</title><link>https://glpladder.com/guides/zepbound-injection-sites/</link><guid isPermaLink="true">https://glpladder.com/guides/zepbound-injection-sites/</guid><description>Zepbound injection sites per the FDA label: abdomen, thigh or back of upper arm, rotation, the KwikPen 2-inch rule, site reactions and storage by presentation.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Using the label</category><category>tirzepatide</category></item></channel></rss>